Skip to main content
Erschienen in: Current Gastroenterology Reports 9/2015

01.09.2015 | Esophagus (JO Clarke, Section Editor)

Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update

verfasst von: Thomas M. Runge, Evan S. Dellon

Erschienen in: Current Gastroenterology Reports | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

The mechanisms underlying eosinophilic esophagitis (EoE) have been intensely investigated, and significant advances have been made in understanding the pathogenesis of EoE. EoE is defined as a chronic immune/antigen-mediated disease, characterized clinically by symptoms of esophageal dysfunction and histologically by an esophageal eosinophilic infiltrate. In this paper, we will review the current knowledge of EoE pathophysiology based on both animal and human data and discuss possible etiologic mechanisms from the genetic and environmental perspectives. EoE is a Th2-predominant inflammatory process triggered by allergens. Proinflammatory cytokines and chemokines recruit eosinophils and other effector cells, such as mast cells, into the esophageal epithelium, where they cause direct damage and promote esophageal remodeling. The genetic expression profile of EoE has been described, and several single nucleotide polymorphisms have been identified and associated with EoE. While this genetic contribution is important, it is difficult to postulate that EoE is primarily a genetic disease. Given the rapid epidemiologic changes in the incidence and prevalence of EoE over the past two decades, environmental factors may be the driving force. While it is not known what causes EoE in an individual patient at a specific time, the current hypothesis is that there is a complex interaction between genetic factors and environmental exposures that remains to be elucidated.
Literatur
1.
Zurück zum Zitat Liacouras CA. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20. e6.PubMedCrossRef Liacouras CA. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20. e6.PubMedCrossRef
2.
Zurück zum Zitat Furuta GT et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment: sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Gastroenterology. 2007;133(4):1342–63.PubMedCrossRef Furuta GT et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment: sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Gastroenterology. 2007;133(4):1342–63.PubMedCrossRef
3.•
Zurück zum Zitat Dellon ES. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92. The most recent updated clinical guidelines for diagnosis and management of esophageal eosinophilia and EoE.PubMedCrossRef Dellon ES. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92. The most recent updated clinical guidelines for diagnosis and management of esophageal eosinophilia and EoE.PubMedCrossRef
5.
Zurück zum Zitat Collins MH et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol. 2008;6(6):621–9.PubMedPubMedCentralCrossRef Collins MH et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol. 2008;6(6):621–9.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol. 2011;18(5):335–48.PubMedCrossRef Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol. 2011;18(5):335–48.PubMedCrossRef
7.
Zurück zum Zitat Aceves SS. Eosinophilic esophagitis. Immunol Allergy Clin N Am. 2015;35:145–59.CrossRef Aceves SS. Eosinophilic esophagitis. Immunol Allergy Clin N Am. 2015;35:145–59.CrossRef
8.
Zurück zum Zitat Spergel JM et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30–6.PubMedCrossRef Spergel JM et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30–6.PubMedCrossRef
9.
Zurück zum Zitat Kapel RC et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134(5):1316–21.PubMedCrossRef Kapel RC et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134(5):1316–21.PubMedCrossRef
10.
Zurück zum Zitat Dellon ES et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102(10):2300–13.PubMedCrossRef Dellon ES et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102(10):2300–13.PubMedCrossRef
11.
Zurück zum Zitat Dellon ES et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305–13.PubMedPubMedCentralCrossRef Dellon ES et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305–13.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Prasad GA et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County. Minnesota Clin Gastroenterol Hepatol. 2009;7(10):1055–61.PubMedCrossRef Prasad GA et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County. Minnesota Clin Gastroenterol Hepatol. 2009;7(10):1055–61.PubMedCrossRef
14.
Zurück zum Zitat Mackenzie S et al. Eosinophilic oesophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28(9):1140–6.PubMedCrossRef Mackenzie S et al. Eosinophilic oesophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28(9):1140–6.PubMedCrossRef
15.
Zurück zum Zitat Veerappan GR et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009;7(4):420–6. e2.PubMedCrossRef Veerappan GR et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009;7(4):420–6. e2.PubMedCrossRef
16.
Zurück zum Zitat Franciosi JP et al. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7(4):415–9.PubMedCrossRef Franciosi JP et al. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7(4):415–9.PubMedCrossRef
17.
18.
Zurück zum Zitat Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):201–18.CrossRef Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):201–18.CrossRef
19.
Zurück zum Zitat Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child. 2006;91(12):1000–4.PubMedPubMedCentralCrossRef Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child. 2006;91(12):1000–4.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Hruz P et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128(6):1349–50. e5.PubMedCrossRef Hruz P et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128(6):1349–50. e5.PubMedCrossRef
21.
Zurück zum Zitat Syed A et al. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population‐based study. Aliment Pharmacol Ther. 2012;36(10):950–8.PubMedCrossRef Syed A et al. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population‐based study. Aliment Pharmacol Ther. 2012;36(10):950–8.PubMedCrossRef
22.
Zurück zum Zitat Prasad GA et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102(12):2627–32.PubMedCrossRef Prasad GA et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102(12):2627–32.PubMedCrossRef
23.
Zurück zum Zitat Ricker J. et al. Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Therapeutic Adv Gastroenterol, 2010: p. 1756283X10384172. Ricker J. et al. Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Therapeutic Adv Gastroenterol, 2010: p. 1756283X10384172.
24.
Zurück zum Zitat Dellon E.S., et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013. Dellon E.S., et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013.
25.
Zurück zum Zitat Desai TK et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.PubMedCrossRef Desai TK et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.PubMedCrossRef
26.
Zurück zum Zitat Hurtado CW, Furuta GT, Kramer RE. Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr. 2011;52(1):43–6.PubMedCrossRef Hurtado CW, Furuta GT, Kramer RE. Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr. 2011;52(1):43–6.PubMedCrossRef
27.
Zurück zum Zitat Kerlin P et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007;41(4):356–61.PubMedCrossRef Kerlin P et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007;41(4):356–61.PubMedCrossRef
28.
Zurück zum Zitat Sperry SL et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74(5):985–91.PubMedPubMedCentralCrossRef Sperry SL et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74(5):985–91.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Kidambi T et al. Temporal trends in the relative prevalence of dysphagia etiologies from 1999–2009. World J Gastroenterol: WJG. 2012;18(32):4335.PubMedPubMedCentralCrossRef Kidambi T et al. Temporal trends in the relative prevalence of dysphagia etiologies from 1999–2009. World J Gastroenterol: WJG. 2012;18(32):4335.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Dellon ES et al. S1972 increasing incidence of eosinophilic esophagitis: a persistent trend after accounting for procedure indication and biopsy rate. Gastroenterology. 2008;134(4):A-289. Dellon ES et al. S1972 increasing incidence of eosinophilic esophagitis: a persistent trend after accounting for procedure indication and biopsy rate. Gastroenterology. 2008;134(4):A-289.
31.
Zurück zum Zitat Dellon E, Erichsen R, Baron J. The increasing incidence and prevalence of eosinophilic esophagitis outpaces changes in endoscopic and biopsy practice: National population-based estimates from Denmark (abstr Mo1829). Gastroenterology. 2014;146 suppl 1:665. Dellon E, Erichsen R, Baron J. The increasing incidence and prevalence of eosinophilic esophagitis outpaces changes in endoscopic and biopsy practice: National population-based estimates from Denmark (abstr Mo1829). Gastroenterology. 2014;146 suppl 1:665.
33.
Zurück zum Zitat Straumann A et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108(6):954–61.PubMedCrossRef Straumann A et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108(6):954–61.PubMedCrossRef
34.
35.
Zurück zum Zitat Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003;125(5):1419–27.PubMedCrossRef Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003;125(5):1419–27.PubMedCrossRef
36.
Zurück zum Zitat Akei HS et al. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129(3):985–94.PubMedCrossRef Akei HS et al. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129(3):985–94.PubMedCrossRef
38.
Zurück zum Zitat Mishra A et al. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2007;81(4):916–24.PubMedCrossRef Mishra A et al. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2007;81(4):916–24.PubMedCrossRef
39.
Zurück zum Zitat Mishra A et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168(5):2464–9.PubMedCrossRef Mishra A et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168(5):2464–9.PubMedCrossRef
40.•
Zurück zum Zitat Masterson JC et al. Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis. Gut. 2014;63(1):43–53. This paper describes development and features of a novel murine model of EoE. PubMedCrossRef Masterson JC et al. Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis. Gut. 2014;63(1):43–53. This paper describes development and features of a novel murine model of EoE. PubMedCrossRef
41.
Zurück zum Zitat Rayapudi M et al. Invariant natural killer T cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Translat Immunol. 2014;3(1):e9.CrossRef Rayapudi M et al. Invariant natural killer T cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Translat Immunol. 2014;3(1):e9.CrossRef
42.••
Zurück zum Zitat Noti M et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med. 2013;19(8):1005–13. An important invesigation of potential mechanisms of TSLP involvement in EoE pathogenesis, and one of the first reports about the possible role of basophil responses in EoE. PubMedPubMedCentralCrossRef Noti M et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med. 2013;19(8):1005–13. An important invesigation of potential mechanisms of TSLP involvement in EoE pathogenesis, and one of the first reports about the possible role of basophil responses in EoE. PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Straumann A, Simon H-U. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115(2):418–9.PubMedCrossRef Straumann A, Simon H-U. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115(2):418–9.PubMedCrossRef
44.
Zurück zum Zitat Jyonouchi S, Brown-Whitehorn TA, Spergel JM. Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin N Am. 2009;29(1):85–97.CrossRef Jyonouchi S, Brown-Whitehorn TA, Spergel JM. Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin N Am. 2009;29(1):85–97.CrossRef
45.
Zurück zum Zitat Assa’ad AH et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731–8.PubMedCrossRef Assa’ad AH et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731–8.PubMedCrossRef
46.
Zurück zum Zitat Simon D et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115(5):1090–2.PubMedCrossRef Simon D et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115(5):1090–2.PubMedCrossRef
47.
Zurück zum Zitat Assa’ad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am. 2008;18(1):119–32.PubMedCrossRef Assa’ad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am. 2008;18(1):119–32.PubMedCrossRef
48.
Zurück zum Zitat Penfield JD et al. The role of allergy evaluation in adults with eosinophilic esophagitis. J Clin Gastroenterol. 2010;44(1):22–7.PubMedCrossRef Penfield JD et al. The role of allergy evaluation in adults with eosinophilic esophagitis. J Clin Gastroenterol. 2010;44(1):22–7.PubMedCrossRef
49.
Zurück zum Zitat Roy–Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531–5.PubMedCrossRef Roy–Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531–5.PubMedCrossRef
50.
Zurück zum Zitat Rhijn B et al. Birch pollen sensitization with cross‐reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy. 2013;68(11):1475–81.PubMedCrossRef Rhijn B et al. Birch pollen sensitization with cross‐reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy. 2013;68(11):1475–81.PubMedCrossRef
51.
Zurück zum Zitat Spergel JM et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann AllerG, Asthma Immunol. 2005;95(4):336–43.CrossRef Spergel JM et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann AllerG, Asthma Immunol. 2005;95(4):336–43.CrossRef
52.
Zurück zum Zitat Spergel JM. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol. 2007;7(3):274–8.PubMedCrossRef Spergel JM. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol. 2007;7(3):274–8.PubMedCrossRef
53.
Zurück zum Zitat Kelly KJ et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–12.PubMedCrossRef Kelly KJ et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–12.PubMedCrossRef
54.
Zurück zum Zitat Markowitz JE et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.PubMedCrossRef Markowitz JE et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.PubMedCrossRef
55.
Zurück zum Zitat Kagalwalla AF et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.PubMedCrossRef Kagalwalla AF et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.PubMedCrossRef
56.
Zurück zum Zitat Liacouras CA et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.PubMedCrossRef Liacouras CA et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.PubMedCrossRef
57.
Zurück zum Zitat Peterson KA et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):759–66.PubMedCrossRef Peterson KA et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):759–66.PubMedCrossRef
58.
Zurück zum Zitat Assa’ad A. Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allerg, Asthma Immunol. 2005;95(4):309–11.CrossRef Assa’ad A. Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allerg, Asthma Immunol. 2005;95(4):309–11.CrossRef
59.
Zurück zum Zitat Henderson CJ et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129(6):1570–8.PubMedPubMedCentralCrossRef Henderson CJ et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129(6):1570–8.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Wolf W.A., et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clini Gastroenterol Hepatol 2014. Wolf W.A., et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clini Gastroenterol Hepatol 2014.
61.••
Zurück zum Zitat Arias Á et al. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–48. A comprehensive meta-analysis of dietary elimination therapy in EoE, highlighting that the repsonse to removal of food triggers supports the allergic hypothesis of EoE etiology. PubMedCrossRef Arias Á et al. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–48. A comprehensive meta-analysis of dietary elimination therapy in EoE, highlighting that the repsonse to removal of food triggers supports the allergic hypothesis of EoE etiology. PubMedCrossRef
62.
Zurück zum Zitat Gonsalves N et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9. e1.PubMedCrossRef Gonsalves N et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9. e1.PubMedCrossRef
63.
Zurück zum Zitat Lucendo AJ et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.PubMedCrossRef Lucendo AJ et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.PubMedCrossRef
64.
Zurück zum Zitat Molina-Infante J et al. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.PubMedCrossRef Molina-Infante J et al. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.PubMedCrossRef
65.
Zurück zum Zitat Wolf WA, Jerath MR, Dellon ES. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis: JGLD. 2013;22(2):205.PubMedPubMedCentral Wolf WA, Jerath MR, Dellon ES. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis: JGLD. 2013;22(2):205.PubMedPubMedCentral
66.
Zurück zum Zitat Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112(4):796–7.PubMedCrossRef Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112(4):796–7.PubMedCrossRef
67.
Zurück zum Zitat Moawad F et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.PubMedCrossRef Moawad F et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.PubMedCrossRef
68.
Zurück zum Zitat Almansa C et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104(4):828–33.PubMedCrossRef Almansa C et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104(4):828–33.PubMedCrossRef
69.
Zurück zum Zitat Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41(5):451–3.PubMedCrossRef Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41(5):451–3.PubMedCrossRef
70.
Zurück zum Zitat Simon D et al. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy. 2013;68(7):945–8.PubMedCrossRef Simon D et al. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy. 2013;68(7):945–8.PubMedCrossRef
71.
Zurück zum Zitat Uzzaman A. and S.H. Cho. Classification of hypersensitivity reactions. In allergy and asthma proceedings. 2012. OceanSide Publications, Inc. Uzzaman A. and S.H. Cho. Classification of hypersensitivity reactions. In allergy and asthma proceedings. 2012. OceanSide Publications, Inc.
72.
Zurück zum Zitat Bryce PJ et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity. 2004;20(4):381–92.PubMedCrossRef Bryce PJ et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity. 2004;20(4):381–92.PubMedCrossRef
73.
Zurück zum Zitat Rocha R et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011;170(11):1471–4.PubMedCrossRef Rocha R et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011;170(11):1471–4.PubMedCrossRef
74.••
Zurück zum Zitat Clayton F., et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology, 2014. 146(7). This study not only presents the results of a randomized trial of an anti-IgE antibody, but investigates why this medication did not work and identified for the first time the potential role of IgG4 in the pathogenesis of EoE. Clayton F., et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology, 2014. 146(7). This study not only presents the results of a randomized trial of an anti-IgE antibody, but investigates why this medication did not work and identified for the first time the potential role of IgG4 in the pathogenesis of EoE.
75.
Zurück zum Zitat Chetty R, Gatter K. CD3: structure, function, and role of immunostaining in clinical practice. J Pathol. 1994;173(4):303–7.PubMedCrossRef Chetty R, Gatter K. CD3: structure, function, and role of immunostaining in clinical practice. J Pathol. 1994;173(4):303–7.PubMedCrossRef
76.
Zurück zum Zitat Grunow R et al. Masking of pan-T-cell markers in patients with autoimmune diseases. Dermatologische Monatschrift. 1986;173(7):390–9. Grunow R et al. Masking of pan-T-cell markers in patients with autoimmune diseases. Dermatologische Monatschrift. 1986;173(7):390–9.
77.
Zurück zum Zitat Syrbe U., J. Siveke and A. Hamann. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? in Springer seminars in immunopathology. 1999. Springer. Syrbe U., J. Siveke and A. Hamann. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? in Springer seminars in immunopathology. 1999. Springer.
78.
Zurück zum Zitat Zhang Z, Sferra TJ, Eroglu Y. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci. 2013;58(6):1497–506.PubMedCrossRef Zhang Z, Sferra TJ, Eroglu Y. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci. 2013;58(6):1497–506.PubMedCrossRef
79.
Zurück zum Zitat Straumann A et al. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. Inflamm Bowel Dis. 2005;11(8):720–6.PubMedCrossRef Straumann A et al. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. Inflamm Bowel Dis. 2005;11(8):720–6.PubMedCrossRef
80.
Zurück zum Zitat Blanchard C et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120(6):1292–300.PubMedCrossRef Blanchard C et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120(6):1292–300.PubMedCrossRef
81.
Zurück zum Zitat Blanchard C et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127(1):208–17. e7.PubMedPubMedCentralCrossRef Blanchard C et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127(1):208–17. e7.PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Lucendo AJ et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol. 2007;31(4):598–606.PubMedCrossRef Lucendo AJ et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol. 2007;31(4):598–606.PubMedCrossRef
83.
Zurück zum Zitat Blanchard C et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033–41.PubMedCrossRef Blanchard C et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033–41.PubMedCrossRef
84.
Zurück zum Zitat Sherrill J et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718–29.PubMedPubMedCentralCrossRef Sherrill J et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718–29.PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Blanchard C et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008;1(4):289–96.PubMedPubMedCentralCrossRef Blanchard C et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008;1(4):289–96.PubMedPubMedCentralCrossRef
86.•
Zurück zum Zitat Cheng E., et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut, 2012: p. gutjnl-2012-302250. This article presents a novel anti-inflammatory/anti-eosinophilic and acid-independent effect of omperazole, a proton pump inhibitor. Cheng E., et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut, 2012: p. gutjnl-2012-302250. This article presents a novel anti-inflammatory/anti-eosinophilic and acid-independent effect of omperazole, a proton pump inhibitor.
87.
Zurück zum Zitat Straumann A., et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut, 2009: p. gut. 2009.178558. Straumann A., et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut, 2009: p. gut. 2009.178558.
88.
Zurück zum Zitat Spergel JM et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456–63. e3.PubMedCrossRef Spergel JM et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456–63. e3.PubMedCrossRef
89.
Zurück zum Zitat Stein ML et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118(6):1312–9.PubMedCrossRef Stein ML et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118(6):1312–9.PubMedCrossRef
90.
Zurück zum Zitat Assa’ad AH et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593–604.PubMedCrossRef Assa’ad AH et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593–604.PubMedCrossRef
91.
Zurück zum Zitat Otani IM et al. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2013;131(6):1576–82. e2.PubMedPubMedCentralCrossRef Otani IM et al. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2013;131(6):1576–82. e2.PubMedPubMedCentralCrossRef
92.•
Zurück zum Zitat Rothenberg, M.E., et al., Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allerg Clin Immunol, 2014. A proof-of-principle study of a new medication class for treatment of EoE. Rothenberg, M.E., et al., Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allerg Clin Immunol, 2014. A proof-of-principle study of a new medication class for treatment of EoE.
93.
Zurück zum Zitat Johnsson M et al. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J innate Immun. 2011;3(6):594–604.PubMedCrossRef Johnsson M et al. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J innate Immun. 2011;3(6):594–604.PubMedCrossRef
94.
Zurück zum Zitat Lingblom C., et al., Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells. Inflammation, 2014: p. 1–13. Lingblom C., et al., Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells. Inflammation, 2014: p. 1–13.
95.
Zurück zum Zitat Bullock JZ et al. Interplay of adaptive th2 immunity with eotaxin-3/cC chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45(1):22–31.PubMedCrossRef Bullock JZ et al. Interplay of adaptive th2 immunity with eotaxin-3/cC chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45(1):22–31.PubMedCrossRef
96.
97.•
Zurück zum Zitat Furuta, G.T., et al., The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut, 2012. A novel and minimally invasive technique that could have application for diagnosis and monitoring of EoE in the future. Furuta, G.T., et al., The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut, 2012. A novel and minimally invasive technique that could have application for diagnosis and monitoring of EoE in the future.
98.
Zurück zum Zitat Moqbel R et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 1995;155(10):4939–47.PubMed Moqbel R et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 1995;155(10):4939–47.PubMed
99.
Zurück zum Zitat Möller G et al. Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol. 1996;14(5):439–43.PubMedCrossRef Möller G et al. Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol. 1996;14(5):439–43.PubMedCrossRef
101.
Zurück zum Zitat Saffari H et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;133(6):1728–34. e1.PubMedCrossRef Saffari H et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;133(6):1728–34. e1.PubMedCrossRef
102.
Zurück zum Zitat Jacoby D, Gleich G, Fryer A. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Investig. 1993;91(4):1314.PubMedPubMedCentralCrossRef Jacoby D, Gleich G, Fryer A. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Investig. 1993;91(4):1314.PubMedPubMedCentralCrossRef
103.
Zurück zum Zitat Aceves SS et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126(6):1198–204. e4.PubMedCrossRef Aceves SS et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126(6):1198–204. e4.PubMedCrossRef
104.
Zurück zum Zitat Young JD-E et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986;321(6070):613–6.PubMedCrossRef Young JD-E et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986;321(6070):613–6.PubMedCrossRef
105.
Zurück zum Zitat O’Donnell MC et al. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Experiment Med. 1983;157(6):1981–91.CrossRef O’Donnell MC et al. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Experiment Med. 1983;157(6):1981–91.CrossRef
106.
Zurück zum Zitat Aceves SS et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119(1):206–12.PubMedCrossRef Aceves SS et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119(1):206–12.PubMedCrossRef
107.
Zurück zum Zitat Kagalwalla AF et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol. 2012;129(5):1387–96. e67.PubMedPubMedCentralCrossRef Kagalwalla AF et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol. 2012;129(5):1387–96. e67.PubMedPubMedCentralCrossRef
108.
Zurück zum Zitat Lucendo AJ et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol. 2011;128(5):1037–46.PubMedCrossRef Lucendo AJ et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol. 2011;128(5):1037–46.PubMedCrossRef
109.
Zurück zum Zitat Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;303(11):G1175–87.CrossRef Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;303(11):G1175–87.CrossRef
110.
Zurück zum Zitat Gupta SK et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42(1):22–6.PubMedCrossRef Gupta SK et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42(1):22–6.PubMedCrossRef
111.
Zurück zum Zitat Kirsch R et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44(1):20–6.PubMedCrossRef Kirsch R et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44(1):20–6.PubMedCrossRef
112.
Zurück zum Zitat Mueller S et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro‐oesophageal reflux disease on oesophageal biopsy material. Histopathology. 2008;53(6):676–84.PubMedCrossRef Mueller S et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro‐oesophageal reflux disease on oesophageal biopsy material. Histopathology. 2008;53(6):676–84.PubMedCrossRef
113.
Zurück zum Zitat Dellon ES et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2010;106(2):264–71.PubMedPubMedCentralCrossRef Dellon ES et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2010;106(2):264–71.PubMedPubMedCentralCrossRef
115.
Zurück zum Zitat Dellon ES et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015–22.PubMedPubMedCentralCrossRef Dellon ES et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015–22.PubMedPubMedCentralCrossRef
116.
Zurück zum Zitat Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol. 2006;118(5):1054–9.PubMedCrossRef Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol. 2006;118(5):1054–9.PubMedCrossRef
117.
Zurück zum Zitat Adamko D, Lacy P, Moqbel R. Mechanisms of eosinophil recruitment and activation. Curr Allerg Asthma Rep. 2002;2(2):107–16.CrossRef Adamko D, Lacy P, Moqbel R. Mechanisms of eosinophil recruitment and activation. Curr Allerg Asthma Rep. 2002;2(2):107–16.CrossRef
118.
Zurück zum Zitat Denburg JA et al. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol. 2000;106(5):S242–6.PubMedCrossRef Denburg JA et al. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol. 2000;106(5):S242–6.PubMedCrossRef
119.
Zurück zum Zitat Sehmi R et al. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol. 1996;15(5):645–55.PubMedCrossRef Sehmi R et al. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol. 1996;15(5):645–55.PubMedCrossRef
120.
Zurück zum Zitat Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;26:877–900.CrossRef Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;26:877–900.CrossRef
121.
Zurück zum Zitat Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol. 2013;13(2):101–17.PubMedCrossRef Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol. 2013;13(2):101–17.PubMedCrossRef
122.
Zurück zum Zitat Lexmond WS et al. Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy. Am J Gastroenterol. 2014;109(5):646–57.PubMedPubMedCentralCrossRef Lexmond WS et al. Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy. Am J Gastroenterol. 2014;109(5):646–57.PubMedPubMedCentralCrossRef
123.
Zurück zum Zitat Rajavelu P et al. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;302(7):G645–54.CrossRef Rajavelu P et al. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;302(7):G645–54.CrossRef
124.
Zurück zum Zitat Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol. 2010;24(6):873–82.PubMedPubMedCentralCrossRef Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol. 2010;24(6):873–82.PubMedPubMedCentralCrossRef
125.
Zurück zum Zitat Mishra A et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134(1):204–14.PubMedPubMedCentralCrossRef Mishra A et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134(1):204–14.PubMedPubMedCentralCrossRef
126.
Zurück zum Zitat Rubinstein E et al. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011;53(4):409.PubMedPubMedCentralCrossRef Rubinstein E et al. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011;53(4):409.PubMedPubMedCentralCrossRef
127.
Zurück zum Zitat Zuo L et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13Rα2-inhibited pathway. J Immunol. 2010;185(1):660–9.PubMedPubMedCentralCrossRef Zuo L et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13Rα2-inhibited pathway. J Immunol. 2010;185(1):660–9.PubMedPubMedCentralCrossRef
128.
129.
Zurück zum Zitat Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):297–316.CrossRef Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):297–316.CrossRef
130.
Zurück zum Zitat Fontillón M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol. 2012;107(11):1762.PubMedCrossRef Fontillón M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol. 2012;107(11):1762.PubMedCrossRef
131.
Zurück zum Zitat Kwiatek MA et al. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedPubMedCentralCrossRef Kwiatek MA et al. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedPubMedCentralCrossRef
133.•
Zurück zum Zitat Nicodème F et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–1107 e1. This study shows that esophageal compliance can be used to predict treatment outcomes in EoE, and emphasizes the important role that esophageal remodeling plays in the clinical picture of EoE. PubMedPubMedCentralCrossRef Nicodème F et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–1107 e1. This study shows that esophageal compliance can be used to predict treatment outcomes in EoE, and emphasizes the important role that esophageal remodeling plays in the clinical picture of EoE. PubMedPubMedCentralCrossRef
134.
Zurück zum Zitat Malerba G et al. Linkage analysis of chromosome 12 markers in Italian families with atopic asthmatic children. Am J Respir Crit Care Med. 2000;162(4):1587–90.PubMedCrossRef Malerba G et al. Linkage analysis of chromosome 12 markers in Italian families with atopic asthmatic children. Am J Respir Crit Care Med. 2000;162(4):1587–90.PubMedCrossRef
135.
Zurück zum Zitat Straumann A et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125(6):1660–9.PubMedCrossRef Straumann A et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125(6):1660–9.PubMedCrossRef
136.
Zurück zum Zitat Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc. 2005;61(1):165–7.PubMedCrossRef Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc. 2005;61(1):165–7.PubMedCrossRef
137.
138.••
Zurück zum Zitat Alexander ES et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084–1092 e1. A comprehensive assessment of the roles of heritability and environment in EoE. PubMedPubMedCentralCrossRef Alexander ES et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084–1092 e1. A comprehensive assessment of the roles of heritability and environment in EoE. PubMedPubMedCentralCrossRef
139.
Zurück zum Zitat Blanchard C. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(0xc7e4e04):536–47.PubMedPubMedCentralCrossRef Blanchard C. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(0xc7e4e04):536–47.PubMedPubMedCentralCrossRef
140.
Zurück zum Zitat Blanchard C et al. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is upregulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int J Biochem Cell Biol. 2005;37(12):2559–73.PubMedCrossRef Blanchard C et al. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is upregulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int J Biochem Cell Biol. 2005;37(12):2559–73.PubMedCrossRef
141.
Zurück zum Zitat Bhattacharya B et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol. 2007;38(12):1744–53.PubMedCrossRef Bhattacharya B et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol. 2007;38(12):1744–53.PubMedCrossRef
142.
Zurück zum Zitat Lucendo AJ et al. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol. 2008;103(9):2184–93.PubMedCrossRef Lucendo AJ et al. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol. 2008;103(9):2184–93.PubMedCrossRef
143.•
Zurück zum Zitat Sherrill J et al. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun. 2014;15(6):361–9. This study expands the known EoE transcriptome, identifying numberous new targets for future pathogenic investigations. PubMedPubMedCentralCrossRef Sherrill J et al. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun. 2014;15(6):361–9. This study expands the known EoE transcriptome, identifying numberous new targets for future pathogenic investigations. PubMedPubMedCentralCrossRef
146.••
Zurück zum Zitat Kottyan LC et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46(8):895–900. One of three GWAS studies of EoE to date, which identified a novel gene locus, CAPN14, as a potential explanation for esophageal specificity in EoE. PubMedPubMedCentralCrossRef Kottyan LC et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46(8):895–900. One of three GWAS studies of EoE to date, which identified a novel gene locus, CAPN14, as a potential explanation for esophageal specificity in EoE. PubMedPubMedCentralCrossRef
147.
Zurück zum Zitat Sleiman P.M., et al. GWAS identifies four novel eosinophilic esophagitis loci. Nature communications, 2014. 5. Sleiman P.M., et al. GWAS identifies four novel eosinophilic esophagitis loci. Nature communications, 2014. 5.
148.
Zurück zum Zitat Larsson H, Bergquist H, Bove M. The incidence of esophageal bolus impaction is there a seasonal variation? Otolaryngol Head Neck Surg. 2011;144(2):186–90.PubMedCrossRef Larsson H, Bergquist H, Bove M. The incidence of esophageal bolus impaction is there a seasonal variation? Otolaryngol Head Neck Surg. 2011;144(2):186–90.PubMedCrossRef
149.
Zurück zum Zitat Hurrell JM, Genta RM, Dellon ES. Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol. 2012;107(5):698–706.PubMedPubMedCentralCrossRef Hurrell JM, Genta RM, Dellon ES. Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol. 2012;107(5):698–706.PubMedPubMedCentralCrossRef
150.
Zurück zum Zitat Jensen, E., et al. Esophageal eosinophilia and eosinophilic esophagitis are increased in rural areas with low population density: results from a national pathology database. in American Journal Of gastroenterology. 2013. Nature publishing group 75 varick st, 9th flr, New York, NY 10013–1917 USA. Jensen, E., et al. Esophageal eosinophilia and eosinophilic esophagitis are increased in rural areas with low population density: results from a national pathology database. in American Journal Of gastroenterology. 2013. Nature publishing group 75 varick st, 9th flr, New York, NY 10013–1917 USA.
151.
Zurück zum Zitat Elitsur Y et al. Seasonal distribution and eosinophilic esophagitis: the experience in children living in rural communities. J Clin Gastroenterol. 2013;47(3):287–8.PubMedCrossRef Elitsur Y et al. Seasonal distribution and eosinophilic esophagitis: the experience in children living in rural communities. J Clin Gastroenterol. 2013;47(3):287–8.PubMedCrossRef
152.
Zurück zum Zitat Spergel JM et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300–6.PubMedPubMedCentralCrossRef Spergel JM et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300–6.PubMedPubMedCentralCrossRef
153.
Zurück zum Zitat Bonis PA. Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis. Immunol Allergy Clin N Am. 2009;29(1):41–52.CrossRef Bonis PA. Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis. Immunol Allergy Clin N Am. 2009;29(1):41–52.CrossRef
155.
Zurück zum Zitat Dellon ES et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141(5):1586–92.PubMedPubMedCentralCrossRef Dellon ES et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141(5):1586–92.PubMedPubMedCentralCrossRef
156.
Zurück zum Zitat Ronkainen J et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56(5):615–20.PubMedPubMedCentralCrossRef Ronkainen J et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56(5):615–20.PubMedPubMedCentralCrossRef
157.
Zurück zum Zitat Furuta K et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53(1):60.PubMedPubMedCentralCrossRef Furuta K et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53(1):60.PubMedPubMedCentralCrossRef
158.
Zurück zum Zitat Elitsur,Y., et al. Does helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter, 2014. Elitsur,Y., et al. Does helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter, 2014.
159.
Zurück zum Zitat Yamazaki K et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51(11):1934–41.PubMedCrossRef Yamazaki K et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51(11):1934–41.PubMedCrossRef
160.•
Zurück zum Zitat Jensen ET et al. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(1):67–71. The first study showing that selected early life exposures, such as antibiotic use during infancy, can increase the risk of pediatric development of EoE. PubMedCrossRef Jensen ET et al. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(1):67–71. The first study showing that selected early life exposures, such as antibiotic use during infancy, can increase the risk of pediatric development of EoE. PubMedCrossRef
Metadaten
Titel
Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update
verfasst von
Thomas M. Runge
Evan S. Dellon
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 9/2015
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-015-0458-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.